Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 12 | 2026 | 874 | 2.850 |
Why?
|
| Epilepsy, Absence | 5 | 2026 | 36 | 2.380 |
Why?
|
| Anticonvulsants | 5 | 2022 | 363 | 1.840 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2023 | 248 | 1.730 |
Why?
|
| Educational Measurement | 4 | 2026 | 319 | 1.680 |
Why?
|
| Electroencephalography | 15 | 2026 | 859 | 1.480 |
Why?
|
| Seizures | 8 | 2026 | 889 | 1.340 |
Why?
|
| Clinical Competence | 3 | 2025 | 1046 | 1.090 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2025 | 178 | 0.960 |
Why?
|
| Sensory Deprivation | 1 | 2026 | 10 | 0.950 |
Why?
|
| Neurology | 3 | 2025 | 116 | 0.930 |
Why?
|
| Mindfulness | 1 | 2026 | 33 | 0.910 |
Why?
|
| Attention | 1 | 2026 | 192 | 0.840 |
Why?
|
| Gene Dosage | 1 | 2026 | 434 | 0.830 |
Why?
|
| Phenylenediamines | 2 | 2025 | 29 | 0.780 |
Why?
|
| Parvalbumins | 2 | 2022 | 38 | 0.750 |
Why?
|
| KCNQ2 Potassium Channel | 4 | 2025 | 42 | 0.730 |
Why?
|
| Electrocorticography | 3 | 2025 | 54 | 0.670 |
Why?
|
| Students, Medical | 1 | 2025 | 347 | 0.660 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 365 | 0.640 |
Why?
|
| Drug Resistant Epilepsy | 3 | 2025 | 287 | 0.580 |
Why?
|
| Bradycardia | 1 | 2019 | 58 | 0.580 |
Why?
|
| Cerebral Cortex | 4 | 2019 | 445 | 0.580 |
Why?
|
| Epilepsies, Partial | 1 | 2019 | 85 | 0.570 |
Why?
|
| Internship and Residency | 3 | 2026 | 1221 | 0.530 |
Why?
|
| Ethosuximide | 1 | 2017 | 15 | 0.530 |
Why?
|
| Brain Waves | 1 | 2017 | 42 | 0.510 |
Why?
|
| Calcium Channels | 4 | 2026 | 143 | 0.490 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 92 | 0.480 |
Why?
|
| Gamma Rhythm | 1 | 2015 | 11 | 0.470 |
Why?
|
| Mutation | 4 | 2026 | 6059 | 0.430 |
Why?
|
| Clinical Clerkship | 2 | 2025 | 71 | 0.430 |
Why?
|
| Hippocampus | 3 | 2026 | 793 | 0.420 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 914 | 0.410 |
Why?
|
| Neural Pathways | 2 | 2025 | 269 | 0.410 |
Why?
|
| Adult | 16 | 2026 | 31121 | 0.400 |
Why?
|
| Eyelids | 1 | 2014 | 106 | 0.390 |
Why?
|
| Thalamus | 1 | 2014 | 93 | 0.380 |
Why?
|
| Muscular Diseases | 1 | 2014 | 118 | 0.380 |
Why?
|
| Genotype | 1 | 2017 | 2589 | 0.340 |
Why?
|
| Interneurons | 4 | 2022 | 144 | 0.340 |
Why?
|
| KCNQ3 Potassium Channel | 2 | 2023 | 18 | 0.340 |
Why?
|
| Models, Genetic | 1 | 2014 | 749 | 0.330 |
Why?
|
| Mice, Transgenic | 4 | 2026 | 2323 | 0.290 |
Why?
|
| Semantics | 2 | 2026 | 47 | 0.290 |
Why?
|
| Humans | 30 | 2026 | 130534 | 0.290 |
Why?
|
| Male | 19 | 2026 | 64598 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 4 | 2026 | 4702 | 0.280 |
Why?
|
| Mice | 10 | 2026 | 18203 | 0.280 |
Why?
|
| Comorbidity | 2 | 2023 | 1589 | 0.270 |
Why?
|
| Brain | 5 | 2026 | 3165 | 0.270 |
Why?
|
| Competency-Based Education | 2 | 2025 | 83 | 0.260 |
Why?
|
| Calcium Channels, N-Type | 2 | 2017 | 47 | 0.250 |
Why?
|
| Animals | 13 | 2026 | 33739 | 0.250 |
Why?
|
| Disease Models, Animal | 6 | 2026 | 4650 | 0.250 |
Why?
|
| School Admission Criteria | 1 | 2026 | 31 | 0.240 |
Why?
|
| Vibrissae | 1 | 2026 | 14 | 0.240 |
Why?
|
| Multilingualism | 1 | 2026 | 31 | 0.240 |
Why?
|
| Female | 17 | 2026 | 70563 | 0.240 |
Why?
|
| Carbamates | 2 | 2025 | 64 | 0.230 |
Why?
|
| Neurons | 4 | 2026 | 1971 | 0.230 |
Why?
|
| Evoked Potentials | 1 | 2026 | 112 | 0.230 |
Why?
|
| Personnel Selection | 1 | 2026 | 80 | 0.220 |
Why?
|
| Reaction Time | 1 | 2026 | 150 | 0.220 |
Why?
|
| Electric Stimulation | 1 | 2026 | 234 | 0.220 |
Why?
|
| Anesthesia, General | 1 | 2026 | 140 | 0.220 |
Why?
|
| Workplace | 1 | 2025 | 80 | 0.220 |
Why?
|
| Functional Laterality | 1 | 2025 | 176 | 0.210 |
Why?
|
| Lafora Disease | 1 | 2024 | 4 | 0.210 |
Why?
|
| Language | 1 | 2026 | 219 | 0.210 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2024 | 79 | 0.200 |
Why?
|
| Gyrus Cinguli | 1 | 2025 | 131 | 0.200 |
Why?
|
| Connectome | 1 | 2025 | 111 | 0.200 |
Why?
|
| Neuronal Plasticity | 1 | 2026 | 283 | 0.200 |
Why?
|
| Young Adult | 5 | 2026 | 10036 | 0.190 |
Why?
|
| Brain Mapping | 2 | 2023 | 380 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 3 | 2025 | 1075 | 0.190 |
Why?
|
| Gain of Function Mutation | 1 | 2023 | 115 | 0.190 |
Why?
|
| Nerve Net | 1 | 2025 | 253 | 0.180 |
Why?
|
| Receptors, Nicotinic | 1 | 2022 | 113 | 0.180 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2024 | 354 | 0.170 |
Why?
|
| Behavior, Animal | 1 | 2024 | 475 | 0.170 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2021 | 65 | 0.160 |
Why?
|
| Middle Aged | 7 | 2026 | 28424 | 0.160 |
Why?
|
| Monitoring, Physiologic | 1 | 2022 | 371 | 0.160 |
Why?
|
| Lennox Gastaut Syndrome | 1 | 2019 | 8 | 0.150 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 711 | 0.150 |
Why?
|
| Glioma | 1 | 2024 | 494 | 0.150 |
Why?
|
| Age of Onset | 2 | 2019 | 591 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 1266 | 0.130 |
Why?
|
| Sclerosis | 1 | 2017 | 31 | 0.130 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 386 | 0.130 |
Why?
|
| Pyramidal Cells | 3 | 2025 | 151 | 0.130 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2023 | 629 | 0.130 |
Why?
|
| Synaptic Transmission | 1 | 2018 | 299 | 0.120 |
Why?
|
| Defibrillators, Implantable | 1 | 2019 | 215 | 0.120 |
Why?
|
| Visual Cortex | 1 | 2018 | 125 | 0.120 |
Why?
|
| Prevalence | 1 | 2023 | 2692 | 0.120 |
Why?
|
| Mice, Knockout | 1 | 2024 | 3820 | 0.120 |
Why?
|
| Ankyrins | 1 | 2016 | 96 | 0.120 |
Why?
|
| Deep Brain Stimulation | 1 | 2021 | 445 | 0.120 |
Why?
|
| Regression Analysis | 1 | 2017 | 760 | 0.120 |
Why?
|
| Beta Rhythm | 1 | 2015 | 20 | 0.120 |
Why?
|
| Pediatrics | 1 | 2025 | 1249 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2018 | 767 | 0.110 |
Why?
|
| Surveys and Questionnaires | 1 | 2026 | 4057 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2024 | 1306 | 0.110 |
Why?
|
| Molecular Imaging | 1 | 2015 | 58 | 0.110 |
Why?
|
| Homeostasis | 1 | 2018 | 711 | 0.100 |
Why?
|
| Video Recording | 1 | 2015 | 193 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 3751 | 0.100 |
Why?
|
| Cognition | 1 | 2019 | 822 | 0.100 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 1165 | 0.100 |
Why?
|
| Aicardi Syndrome | 1 | 2014 | 17 | 0.100 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 246 | 0.100 |
Why?
|
| Psychophysiologic Disorders | 1 | 2013 | 24 | 0.100 |
Why?
|
| Mass Screening | 1 | 2019 | 821 | 0.100 |
Why?
|
| Bipolar Disorder | 1 | 2016 | 346 | 0.100 |
Why?
|
| Psychotherapy, Brief | 1 | 2013 | 53 | 0.100 |
Why?
|
| Phenotype | 3 | 2019 | 4461 | 0.100 |
Why?
|
| Prognosis | 2 | 2024 | 4866 | 0.100 |
Why?
|
| Spasms, Infantile | 1 | 2014 | 165 | 0.090 |
Why?
|
| Adolescent | 3 | 2026 | 20879 | 0.090 |
Why?
|
| Estradiol | 1 | 2014 | 460 | 0.090 |
Why?
|
| Paraneoplastic Syndromes, Nervous System | 1 | 2011 | 7 | 0.090 |
Why?
|
| Retrospective Studies | 2 | 2022 | 17653 | 0.090 |
Why?
|
| Nystagmus, Pathologic | 1 | 2011 | 23 | 0.080 |
Why?
|
| Status Epilepticus | 1 | 2012 | 159 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 555 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 461 | 0.080 |
Why?
|
| Carcinoma | 1 | 2011 | 291 | 0.070 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 3815 | 0.070 |
Why?
|
| Unconsciousness | 1 | 2026 | 27 | 0.060 |
Why?
|
| Biomarkers | 1 | 2015 | 3366 | 0.060 |
Why?
|
| Acoustic Stimulation | 1 | 2026 | 91 | 0.060 |
Why?
|
| Nonlinear Dynamics | 1 | 2026 | 54 | 0.060 |
Why?
|
| Consciousness | 1 | 2026 | 56 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 739 | 0.060 |
Why?
|
| Models, Neurological | 1 | 2026 | 211 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2024 | 18 | 0.050 |
Why?
|
| Inclusion Bodies | 1 | 2024 | 38 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2014 | 2403 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2024 | 154 | 0.050 |
Why?
|
| Prosencephalon | 1 | 2023 | 39 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 300 | 0.050 |
Why?
|
| Microglia | 1 | 2024 | 145 | 0.050 |
Why?
|
| Cryoelectron Microscopy | 1 | 2025 | 243 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2023 | 154 | 0.050 |
Why?
|
| Affect | 1 | 2023 | 158 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2025 | 298 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 459 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2026 | 552 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 348 | 0.040 |
Why?
|
| Aged | 2 | 2017 | 20899 | 0.040 |
Why?
|
| Emotions | 1 | 2023 | 349 | 0.040 |
Why?
|
| Artifacts | 1 | 2021 | 99 | 0.040 |
Why?
|
| Oocytes | 1 | 2022 | 283 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2022 | 450 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2003 | 759 | 0.040 |
Why?
|
| Sleep | 1 | 2022 | 377 | 0.040 |
Why?
|
| Neuropil | 1 | 2018 | 9 | 0.030 |
Why?
|
| Potassium Channel Blockers | 1 | 2018 | 84 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 947 | 0.030 |
Why?
|
| Transcriptome | 1 | 2024 | 1098 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 356 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 1581 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2016 | 423 | 0.030 |
Why?
|
| Child | 3 | 2022 | 26237 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 308 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2015 | 42 | 0.030 |
Why?
|
| Exons | 1 | 2016 | 759 | 0.030 |
Why?
|
| Spasm | 1 | 2014 | 45 | 0.030 |
Why?
|
| Estrogen Receptor beta | 1 | 2014 | 79 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 283 | 0.020 |
Why?
|
| Biophysics | 1 | 2012 | 47 | 0.020 |
Why?
|
| Electrodes | 1 | 2012 | 81 | 0.020 |
Why?
|
| ELAV Proteins | 1 | 2011 | 14 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 423 | 0.020 |
Why?
|
| United States | 1 | 2026 | 12009 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 5048 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2012 | 671 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1829 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 1362 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 1371 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2827 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2012 | 969 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3422 | 0.010 |
Why?
|
| Isopropyl Thiogalactoside | 1 | 2003 | 1 | 0.010 |
Why?
|
| Melibiose | 1 | 2003 | 1 | 0.010 |
Why?
|
| Operator Regions, Genetic | 1 | 2003 | 5 | 0.010 |
Why?
|
| Lac Repressors | 1 | 2003 | 12 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 2003 | 49 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2003 | 40 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 79 | 0.010 |
Why?
|
| Lactose | 1 | 2003 | 55 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 15029 | 0.010 |
Why?
|
| Urea | 1 | 2003 | 219 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 404 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 716 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2003 | 732 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 2003 | 314 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 12854 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 1936 | 0.010 |
Why?
|